Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Platinum Levels and Neurotoxicity in Oxaliplatin-Treated Gastrointestinal Cancer
NCT00274885Phase 4Unknown
- Sponsor
- GERCOR
- Start
- Oct 2005
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 4 trial of oxaliplatin in gastrointestinal cancer, sponsored by GERCOR. Status: unknown.
02
Drugs
oxaliplatin
03
Conditions
gastrointestinal cancer
Beyond the preview
Go deeper on NCT00274885.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00274885.